Biomatik
Private Company
Funding information not available
Overview
Biomatik is a well-established, privately-held biotech services and reagents company headquartered in Wilmington, Delaware. Since 2002, it has built a strong reputation for delivering high-quality, affordable custom biomolecules (genes, peptides, proteins, antibodies) and a vast catalog of off-the-shelf research tools. With a customer-centric model, high success rates, and publications in top-tier journals validating its products, Biomatik is a trusted partner for academic, government, and pharmaceutical researchers globally. The company is revenue-generating, leveraging a hybrid business model of catalog sales and high-margin custom service contracts.
Technology Platform
Integrated suite of molecular biology and immunology services including gene synthesis, peptide synthesis, recombinant protein production (E. coli), and custom antibody production/sequencing, optimized for high success rates and cost-effectiveness.
Opportunities
Risk Factors
Competitive Landscape
Biomatik competes in the highly competitive life science reagents and contract research services market against large multinational corporations (e.g., Thermo Fisher, Abcam) and numerous niche players. Its primary competitive differentiation is a strong value proposition combining affirmed quality (via peer-reviewed citations), low-cost guarantees, and responsive customer service, targeting budget-conscious academic and biotech researchers.